Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study
- PMID: 20730462
- DOI: 10.1007/s10072-010-0395-1
Pursuit ocular movements in multiple sclerosis: a video-based eye-tracking study
Abstract
Multiple sclerosis (MS) patients frequently develop some form of ocular motor dysfunction during the disease. In previous studies, ocular motor abnormalities were found to correlate with clinical disability and with impaired cognitive performance. The objective of this study was to assess the pursuit ocular movement (POM) frequency in relapsing-remitting (RR) and secondary progressive (SP) MS patients by using a vision-based non-intrusive eye tracker. POM frequency was significantly lower (p < 0.001) in MS patients compared to normal controls. No differences between RR and SP-MS patients and no correlation between POM and expanded disability status scale (EDSS) score were found. This exploratory study suggests that our vision-based system is a new simple non-intrusive method showing impairment of POM values in MS patients, even in the absence of association with clinical disability (EDSS). Future works on larger cohorts of MS patients might validate this eye tracking in MS clinical practice.
Similar articles
-
Toward an Automatic Assessment of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis Patients Using Eye Movement Analysis.Sensors (Basel). 2022 Oct 27;22(21):8220. doi: 10.3390/s22218220. Sensors (Basel). 2022. PMID: 36365918 Free PMC article.
-
Correlations Between Oculometric Measures and Traditional Clinical Assessments in Multiple Sclerosis.Mult Scler Relat Disord. 2025 Feb;94:106265. doi: 10.1016/j.msard.2025.106265. Epub 2025 Jan 10. Mult Scler Relat Disord. 2025. PMID: 39827539
-
Eye movement deficits in Multiple Sclerosis: Characterizing executive problems as the disease worsens.Mult Scler Relat Disord. 2025 Mar;95:106333. doi: 10.1016/j.msard.2025.106333. Epub 2025 Feb 12. Mult Scler Relat Disord. 2025. PMID: 39970865
-
Methods to Assess Ocular Motor Dysfunction in Multiple Sclerosis.J Neuroophthalmol. 2018 Dec;38(4):488-493. doi: 10.1097/WNO.0000000000000734. J Neuroophthalmol. 2018. PMID: 30418331 Review.
-
Mitoxantrone: a review of its use in multiple sclerosis.CNS Drugs. 2004;18(6):379-96. doi: 10.2165/00023210-200418060-00010. CNS Drugs. 2004. PMID: 15089110 Review.
Cited by
-
Digital Biomarkers in Multiple Sclerosis.Brain Sci. 2021 Nov 16;11(11):1519. doi: 10.3390/brainsci11111519. Brain Sci. 2021. PMID: 34827518 Free PMC article. Review.
-
Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease.Neuropsychiatr Dis Treat. 2014 Jul 9;10:1273-85. doi: 10.2147/NDT.S55371. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25031536 Free PMC article. Review.
-
Bedside tested ocular motor disorders in multiple sclerosis patients.Mult Scler Int. 2014;2014:732329. doi: 10.1155/2014/732329. Epub 2014 Apr 30. Mult Scler Int. 2014. PMID: 24876966 Free PMC article.
-
Toward an Automatic Assessment of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis Patients Using Eye Movement Analysis.Sensors (Basel). 2022 Oct 27;22(21):8220. doi: 10.3390/s22218220. Sensors (Basel). 2022. PMID: 36365918 Free PMC article.
-
Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment.Front Ophthalmol (Lausanne). 2024 Jul 22;4:1354892. doi: 10.3389/fopht.2024.1354892. eCollection 2024. Front Ophthalmol (Lausanne). 2024. PMID: 39104603 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical